AI Article Synopsis

  • - The study aimed to evaluate the safety, effectiveness, and tolerability of Naltrexone in treating alcohol use disorder in patients with alcohol-related cirrhosis.
  • - After 4 weeks of treatment, there were notable reductions in liver enzyme levels, self-reported craving, AUDIT scores, and the number of drinking days, indicating potential benefits.
  • - The findings suggest that Naltrexone is safe and effective for managing alcohol use disorder in patients with liver complications, supporting its clinical use in these cases.

Article Abstract

Background And Aims: Naltrexone is a promising drug to treat alcohol use disorder with limited evidence of safety in liver diseases. An observational study was performed to study the safety, effectiveness, and tolerability of Naltrexone in the management of alcohol use disorder in patients with alcohol-associated cirrhosis.

Methods: Naltrexone was started in patients with alcohol-related liver disease for the management of alcohol use disorder in 86 patients who were followed up for 4 weeks. Baseline liver parameters were compared with those at 4 weeks to establish safety of the drug. Effectiveness was determined by observing reduction in AUDIT scores, craving, number and days of drinking. Self-report of side effects was noted.

Results: After 4 weeks of starting Naltrexone there was a decrease in AST-89.86 vs 57.61, ALT-50.19 vs 27.08, SAP-121.81 vs 98.19, GGT-166.93 vs 109 and MELD 16.32 vs 12.13 (none statistically significant). There was a statistically significant reduction in Serum Bilirubin- (4.31 vs 1.98), INR (1.49 vs 1.32), self-reported craving (3.71 Vs 1.97;  = 0.01), AUDIT scores (24.13 Vs 16.91; <0.01) and number of drinking days in last one month (10.22 Vs 4.19;  = 0.03).

Conclusion: The reduction in all liver parameters and AUDIT scores and craving after treatment with Naltrexone supports its safety and utility in the management of alcohol use disorder in alcohol-related liver cirrhosis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11615892PMC
http://dx.doi.org/10.1016/j.jceh.2024.102447DOI Listing

Publication Analysis

Top Keywords

alcohol disorder
16
management alcohol
12
disorder patients
12
safety effectiveness
8
naltrexone management
8
patients alcohol-associated
8
audit scores
8
naltrexone
5
safety
4
effectiveness naltrexone
4

Similar Publications

Occupational therapy's whole-person approach is well-suited to address the complex needs of children and youth with fetal alcohol spectrum disorder (FASD). However, literature regarding best practices for occupational therapy practitioners working with this population is lacking. This article delineates the role and scope of occupational therapy practice for children and youth with FASD, focusing on holistic and strengths-based approaches.

View Article and Find Full Text PDF

Background: Protecting individual anonymity is a common practice in harm reduction (HR), as it can mitigate the fears that may prevent people from accessing services. Protecting anonymity usually means applying for services with a pseudonym. However, anonymity protection practices have diversified in current HR environments, for example, on the streets or in the Tor network, which relies on technology to guarantee exceptionally strong anonymity.

View Article and Find Full Text PDF

HIV and alcohol misuse among miners in Zimbabwe.

Lancet

December 2025

MRC International Statistics & Epidemiology Group, Department of Infectious Disease Epidemiology, University of Washington in St. Louis, St. Louis, MO, USA.

View Article and Find Full Text PDF

Maternal separation stress increases alcohol preference regardless of DNA methylation and histone acetylation or methylation in the amygdala.

Physiol Behav

December 2024

Molecular and Behavioral Neuroscience Laboratory, Pharmacology Department, Universidade Federal de São Paulo, Brazil.

Alcohol use disorder (AUD) is a condition with multifactorial causes, including biopsychosocial factors. Childhood exposure to stress may increase susceptibility to AUD in adulthood. Despite its significance, the interaction between stress and AUD remains unclear.

View Article and Find Full Text PDF

Myristica fragrans water extract modulates multiple biological processes to pre-protect anhydrous ethanol-induced gastric ulcers via Akt/JNK/Nrf2 pathway activation.

J Ethnopharmacol

December 2024

Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China; State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs; Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, PR China; Key Laboratory of new drug discovery based on Classic Chinese medicine prescription, Chinese Academy of Medical Sciences; NMPA Key Laboratory for Research and Evaluation of Pharmacovigilance. Electronic address:

Ethnopharmacological Relevance: Myristica fragrans (Nutmeg) is a commonly used Chinese herbal medicine and edible spice. According to Pharmacopoeia of People's Republic of China, it has the effects of warming the middle and promoting qi, astringent intestines, and antidiarrheal. In the record of Compendium of Materia Medica, it is the myristica fragrans water extract (MFWE) that is utilized for therapeutic purposes of gastrointestinal disorders frequently.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!